{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:35:22Z","timestamp":1782923722044,"version":"3.54.5"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Exendin-4 (Ex4), a long-lasting glucagon-like peptide-1 analog, was reported to exert favourable actions on inhibiting cocaine-associated rewarding and reinforcing effects of drug in animal models of addiction. However, the therapeutic potential of different dose of GLP-1 receptor agonist Ex4 in different behavioral paradigms and the underlying pharmacological mechanisms of action are incompletely understood. Herein, we firstly investigated the effects of Ex4 on cocaine-induced condition place preference (CPP) as well as extinction and reinstatement in male C57BL\/6J mice. Additionally, we sought to elucidate the underlying pharmacological mechanism of these actions of Ex4. The paradigm of cocaine-induced CPP was established using 20\u00a0mg\/kg cocaine or saline alternately during conditioning, while the reinstatement paradigm was modeled using 10\u00a0mg\/kg cocaine on the reinstatement day. Different dose of Ex4 was administrated intraperitoneally either during conditioning or during extinction state or only on the test day. To elucidate the molecular mechanism underlying the potential effects of Ex4 on maladaptive behaviors of cocaine, the TLR4-related inflammation within the hippocampus was observed by immunofluorescence staining, and the expression levels of toll-like receptor 4 (TLR4), tumor necrosis factor (TNF)-\u03b1, and interleukin (IL)-1\u03b2 were detected by Western blotting. As a consequence, systemic administration of different dose of Ex4 was sufficient to inhibit the acquisition and expression of cocaine-induced CPP, facilitate the extinction of cocaine-associated reward and attenuate reinstatement of cocaine-induced behavior. Furthermore, Ex4 treatment diminished expression levels of TLR4, TNF-\u03b1, and IL-1\u03b2, which were up-regulated by cocaine exposure. Altogether, our results indicated that Ex4 effectively ameliorated cocaine-induced behaviors likely through neurobiological mechanisms partly attributable to the inhibition of TLR4, TNF-\u03b1 and IL-1\u03b2 in mice. Consequently, our findings improved our understanding of the efficacy of Ex4 for the amelioration of cocaine-induced behavior and suggested that Ex4 may be applied as a drug candidate for cocaine addiction.<\/jats:p>","DOI":"10.3389\/fphar.2021.694476","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T12:59:03Z","timestamp":1626699543000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Cocaine-Mediated Behavior by Inhibiting Toll-Like Receptor 4 Signaling in Mice"],"prefix":"10.3389","volume":"12","author":[{"given":"Changliang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikuo","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caibing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haigang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1210\/jc.2011-1508","article-title":"Exenatide Exerts a Potent Antiinflammatory Effect","volume":"97","author":"Ajay","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like Peptide 1 in Health and Disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/adb.12156","article-title":"Plasma Profile of Pro-inflammatory Cytokines and Chemokines in Cocaine Users under Outpatient Treatment: Influence of Cocaine Symptom Severity and Psychiatric Co-morbidity","volume":"20","author":"Araos","year":"2015","journal-title":"Addict. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned Place Preference: what Does it Add to Our Preclinical Understanding of Drug Reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1523\/JNEUROSCI.2212-10.2011","article-title":"Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-like Peptide-1 Loss of Function","volume":"31","author":"Barrera","year":"2011","journal-title":"J. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-420118-7.00001-9","article-title":"Glial Modulators as Potential Treatments of Psychostimulant Abuse","volume":"69","author":"Beardsley","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and Inflammation-Mediated Neurodegeneration: Multiple Triggers with a Common Mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hipo.20313","article-title":"Posterior Parahippocampal Place Learning in H.M","volume":"17","author":"Bohbot","year":"2007","journal-title":"Hippocampus"},{"key":"B11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbr.2006.05.012","article-title":"D-cycloserine Facilitates Extinction of a Cocaine-Induced Conditioned Place Preference","volume":"172","author":"Botreau","year":"2006","journal-title":"Behav. Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/0022034510381264","article-title":"TLR-signaling Networks: an Integration of Adaptor Molecules, Kinases, and Cross-Talk","volume":"90","author":"Brown","year":"2011","journal-title":"J. Dent. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11064-011-0410-9","article-title":"Acute Cocaine Increases Interleukin-1\u03b2 mRNA and Immunoreactive Cells in the Cortex and Nucleus Accumbens","volume":"36","author":"Cearley","year":"2011","journal-title":"Neurochem. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1073\/pnas.0600905103","article-title":"Abolished Cocaine Reward in Mice with a Cocaine-Insensitive Dopamine Transporter","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of Neuroinflammation in Neurodegenerative Diseases (Review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/adb.12337","article-title":"Recent Developments in the Behavioural and Pharmacological Enhancement of Extinction of Drug Seeking","volume":"22","author":"Chesworth","year":"2017","journal-title":"Addict. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12640-012-9334-7","article-title":"Psychostimulant Abuse and Neuroinflammation: Emerging Evidence of Their Interconnection","volume":"23","author":"Clark","year":"2013","journal-title":"Neurotox. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pharmthera.2012.01.008.35","article-title":"Implications of central Immune Signaling Caused by Drugs of Abuse: Mechanisms, Mediators and New Therapeutic Approaches for Prediction and Treatment of Drug Dependence","volume":"134","author":"Coller","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neubiorev.2020.01.001","article-title":"Can Cocaine-Induced Neuroinflammation Explain Maladaptive Cocaine-Associated Memories?","volume":"111","author":"Correia","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00213-017-4560-636","article-title":"Toll-like Receptor Signaling and Stages of Addiction","volume":"234","author":"Crews","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1196\/annals.1369.043","article-title":"Hippocampal Synaptic Plasticity and Water Maze Learning in Cocaine Self-Administered Rats","volume":"1074","author":"Del Olmo","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The Incretin System: Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e69010","DOI":"10.1371\/journal.pone.0069010","article-title":"The Glucagon-like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"Plos. One."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/S0140-6736(14)61335-0","article-title":"Glucagon-like Peptide-1 Receptor Agonist and Basal Insulin Combination Treatment for the Management of Type 2 Diabetes: a Systematic Review and Meta-Analysis","volume":"384","author":"Eng","year":"2014","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40263-014-0178-y","article-title":"Role of Appetite-Regulating Peptides in the Pathophysiology of Addiction: Implications for Pharmacotherapy","volume":"28","author":"Engel","year":"2014","journal-title":"Cns. Drugs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00210-020-01867-5","article-title":"Reduction of Hippocampal Il-6 Levels in Lps-Injected Rats Following Acute Exendin-4 Treatment","volume":"393","author":"G\u00e9a","year":"2020","journal-title":"Naunyn-schmiedeberg's Arch. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: Far beyond an Antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.peptides.2017.11.017","article-title":"GLP-1 Receptor Agonists Show Neuroprotective Effects in Animal Models of Diabetes","volume":"100","author":"Gault","year":"2018","journal-title":"Peptides"},{"key":"B32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/mp.2012.141","article-title":"GLP-1 Analog Attenuates Cocaine Reward","volume":"18","author":"Graham","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","article-title":"Hindbrain Neurons as an Essential Hub in the Neuroanatomically Distributed Control of Energy Balance","volume":"16","author":"Grill","year":"2012","journal-title":"Cel. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/WNR.0b013e32832fbf14","article-title":"Receptors for the Incretin Glucagon-like Peptide-1 Are Expressed on Neurons in the central Nervous System","volume":"20","author":"Hamilton","year":"2009","journal-title":"Neuroreport"},{"key":"B35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.it.2012.03.001","article-title":"Toll-like Receptor (TLR) and Inflammasome Actions in the central Nervous System","volume":"33","author":"Hanamsagar","year":"2012","journal-title":"Trends. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1007\/s00125-010-1831-8","article-title":"A Glucagon-like Peptide-1 (GLP-1) Analogue, Liraglutide, Upregulates Nitric Oxide Production and Exerts Anti-inflammatory Action in Endothelial Cells","volume":"53","author":"Hattori","year":"2010","journal-title":"Diabetologia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cobeha.2016.02.005","article-title":"Glp-1 Influences Food and Drug Reward","volume":"9","author":"Hayes","year":"2016","journal-title":"Curr. Opin. Behav. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0306-4603(90)90043-w","article-title":"Cue Exposure as a Practical Treatment for Addictive Disorders: Why Are We Waiting?","volume":"15","author":"Heather","year":"1990","journal-title":"Addict. Behav."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s41386-018-0010-3","article-title":"Glucagon-like Peptide-1 Receptor Activation in the Ventral Tegmental Area Attenuates Cocaine Seeking in Rats","volume":"43","author":"Hernandez","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.physbeh.2019.03.026","article-title":"Central Glp-1 Receptors: Novel Molecular Targets for Cocaine Use Disorder","volume":"206","author":"Hernandez","year":"2019","journal-title":"Physiol. Behav"},{"key":"B91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/157488910791213130","article-title":"Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer\u2019s disease","volume":"5","author":"Holscher","year":"2010","journal-title":"Recent. Pat. CNS Drug Discov."},{"key":"B41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1185\/03007995.2010.549466","article-title":"Neuroprotective Properties of GLP-1: Theoretical and Practical Applications","volume":"27","author":"Holst","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The Physiology of Glucagon-like Peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"B43","article-title":"State Estimates of Past Year Cocaine Use Among Young Adults: 2014 and 2015","volume-title":"Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration","author":"Hughes","year":"2016"},{"key":"B44","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","article-title":"Opioid Activation of Toll-like Receptor 4 Contributes to Drug Reinforcement","volume":"32","author":"Hutchinson","year":"2012","journal-title":"J. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuropharm.2013.05.039.37","article-title":"Why Is Neuroimmunopharmacology Crucial for the Future of Addiction Research?","author":"Hutchinson","year":"2014","journal-title":"Neuropharmacology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejphar.2010.10.008","article-title":"The Glucagon-like Peptide 1 Receptor Agonist Exendin-4 Improves Reference Memory Performance and Decreases Immobility in the Forced Swim Test","volume":"650","author":"Isacson","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ar.22641","article-title":"Quantitative Analysis of Histological Staining and Fluorescence Using Imagej","volume":"296","author":"Jensen","year":"2013","journal-title":"Anat. Rec. (Hoboken)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.11.005","article-title":"Gut-brain axis and Addictive Disorders: a Review with Focus on Alcohol and Drugs of Abuse","volume":"196","author":"Jerlhag","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/npp.2015.4","article-title":"CRF-amplified Neuronal TLR4\/MCP-1 Signaling Regulates Alcohol Self-Administration","volume":"40","author":"June","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrn3105","article-title":"Common Cellular and Molecular Mechanisms in Obesity and Drug Addiction","volume":"12","author":"Kenny","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1585183","article-title":"Modality-specific Retrograde Amnesia of Fear","volume":"256","author":"Kim","year":"1992","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pbb.2019.01.007","article-title":"Neuroinflammation in Addiction: a Review of Neuroimaging Studies and Potential Immunotherapies","volume":"179","author":"Kohno","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/npp.2016.121","article-title":"Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse","volume":"42","author":"Lacagnina","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/adb.12612","article-title":"Lysophosphatidic Acid\u2010induced Increase in Adult Hippocampal Neurogenesis Facilitates the Forgetting of Cocaine\u2010contextual Memory","volume":"24","author":"Ladr\u00f3n de Guevara\u2010Miranda","year":"2018","journal-title":"Addict. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1677\/joe.0.1690205","article-title":"Hormones and the hippocampus","volume":"169","author":"Lathe","year":"2001","journal-title":"J. Endocrinol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the Distribution and Morphology of Microglia in the normal Adult Mouse Brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3094642","DOI":"10.1155\/2016\/3094642","article-title":"Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/science.278.5335.45","article-title":"Addiction Is a Brain Disease, and it Matters","volume":"278","author":"Leshner","year":"1997","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e32008","DOI":"10.1371\/journal.pone.0032008","article-title":"Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis","volume":"7","author":"Li","year":"2012","journal-title":"Plos. ONE."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"Glp-1 Receptor Stimulation Preserves Primary Cortical and Dopaminergic Neurons in Cellular and Rodent Models of Stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3233\/JAD-2010-1314","article-title":"GLP-1 Receptor Stimulation Reduces Amyloid-\u03b2 Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease","volume":"19","author":"Li","year":"2010","journal-title":"Jad"},{"key":"B93","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/svn-2016-000012","article-title":"Neurotransmitter receptors on microglia","volume":"1","author":"Liu","year":"2016","journal-title":"Stroke Vasc. Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based Therapies for Type 2 Diabetes Mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.16\/0306-4603(90)90048-3","article-title":"Cue Exposure and Relapse Prevention in the Treatment of Addictive Behaviors","volume":"15","author":"Marlatt","year":"1990","journal-title":"Addict. Behav."},{"key":"B64","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2337\/diabetes.53.3.654","article-title":"Secretion, Degradation, and Elimination of Glucagon-like Peptide 1 and Gastric Inhibitory Polypeptide in Patients with Chronic Renal Insufficiency and Healthy Control Subjects","volume":"53","author":"Meier","year":"2004","journal-title":"Diabetes"},{"key":"B66","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0306-4603(90)90048-39861(19990111)403:2<261::aid-cne8>3.0.co;2-5","article-title":"Distribution of Pre-pro-glucagon and Glucagon-like Peptide-1 Receptor Messenger RNAs in the Rat central Nervous System","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nn.4334","article-title":"Shifted Pallidal Co-release of GABA and Glutamate in Habenula Drives Cocaine Withdrawal and Relapse","volume":"19","author":"Meye","year":"2016","journal-title":"Nat. Neurosci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1097\/00001756-200311140-00023","article-title":"Dorsal, but Not Ventral, Hippocampal Lesions Disrupt Cocaine Place Conditioning","volume":"14","author":"Meyers","year":"2003","journal-title":"Neuroreport"},{"key":"B69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1037\/0735-7044.120.2.401","article-title":"Dorsal hippocampus Inhibition Disrupts Acquisition and Expression, but Not Consolidation, of Cocaine Conditioned Place Preference","volume":"120","author":"Meyers","year":"2006","journal-title":"Behav. Neurosci."},{"key":"B70","unstructured":"World Drug Report 2020\n            NiazK.\n            HaarK.\n            CarpentierC.\n            PietchmanT.\n          2020"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/mp.2014.177","article-title":"DAT Isn't All that: Cocaine Reward and Reinforcement Require Toll-like Receptor 4 Signaling","volume":"20","author":"Northcutt","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.278.5335.66","article-title":"A Range of Research-Based Pharmacotherapies for Addiction","volume":"278","author":"O'Brien","year":"1997","journal-title":"Science"},{"key":"B73","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00213-008-1280-y","article-title":"The Facilitative Effects of D-Cycloserine on Extinction of a Cocaine-Induced Conditioned Place Preference Can Be Long Lasting and Resistant to Reinstatement","volume":"202","author":"Paolone","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A Randomized, Controlled Trial of 3.0 Mg of Liraglutide in Weight Management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","article-title":"Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation","volume":"38","author":"Pinho-Ribeiro","year":"2017","journal-title":"Trends Immunolimmunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.tins.2007.07.007","article-title":"Neurotransmitter receptors on microglia","volume":"30","author":"Pocock","year":"2007","journal-title":"Trends Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-801284-0.00012-9","article-title":"Opportunities for the Development of Neuroimmune Therapies in Addiction","volume":"118","author":"Ray","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e809","DOI":"10.1038\/tp.2016.86","article-title":"Glucagon-like Peptide 1 Receptor Activation Regulates Cocaine Actions and Dopamine Homeostasis in the Lateral Septum by Decreasing Arachidonic Acid Levels","volume":"6","author":"Reddy","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brainresbull.2017.09.003","article-title":"Molecular and Synaptic Mechanisms Regulating Drug-Associated Memories: towards a Bidirectional Treatment Strategy","volume":"141","author":"Rich","year":"2018","journal-title":"Brain Res. Bull."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"B80","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.physbeh.2008.12.011","article-title":"Effects of Extended Cocaine Conditioning in the Reinstatement of Place Preference","volume":"96","author":"Rodr\u00edguez-Arias","year":"2009","journal-title":"Physiol. Behav."},{"key":"B92","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2005.09.068","article-title":"Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking","volume":"526","author":"Schmidt","year":"2005","journal-title":"Eur.J. Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1749-6632.2009.05144.x","article-title":"Cocaine-induced Neuroadaptations in Glutamate Transmission: Potential Therapeutic Targets for Craving and Addiction","volume":"1187","author":"Schmidt","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","article-title":"Methamphetamine Causes Microglial Activation in the Brains of Human Abusers","volume":"28","author":"Sekine","year":"2008","journal-title":"J. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fnins.2013.00181","article-title":"The central Glp-1: Implications for Food and Drug Reward","volume":"7","author":"Skibicka","year":"2013","journal-title":"Front. Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.physbeh.2015.06.013","article-title":"The Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Exendin-4 Reduces Cocaine Self-Administration in Mice","volume":"149","author":"S\u00f8rensen","year":"2015","journal-title":"Physiol. Behav."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory Mechanisms in Parkinson's Disease: Potential Environmental Triggers, Pathways, and Targets for Early Therapeutic Intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp. Neurol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fnagi.2017.00150","article-title":"Glia Maturation Factor and Mitochondrial Uncoupling Proteins 2 and 4 Expression in the Temporal Cortex of Alzheimer's Disease Brain","volume":"9","author":"Thangavel","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A Role for Glucagon-like Peptide-1 in the central Regulation of Feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","article-title":"Measuring Reward with the Conditioned Place Preference Paradigm: a Comprehensive Review of Drug Effects, Recent Progress and New Issues","volume":"56","author":"Tzschentke","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nn.3217","article-title":"From Neuroanatomy to Behavior: central Integration of Peripheral Signals Regulating Feeding Behavior","volume":"15","author":"Williams","year":"2012","journal-title":"Nat. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/dia.2010.0048","article-title":"Effect of Exenatide on Inflammatory and Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus","volume":"13","author":"Wu","year":"2011","journal-title":"Diabetes Technol. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.694476\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T12:59:10Z","timestamp":1626699550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.694476\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":90,"alternative-id":["10.3389\/fphar.2021.694476"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.694476","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"article-number":"694476"}}